BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 22496476)

  • 21. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
    Mulenga M; VangGeertruyden JP; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Van Overmeir C; Dujardin JC; D'Alessandro U
    Malar J; 2006 Aug; 5():73. PubMed ID: 16923176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.
    Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA
    Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.
    Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O
    Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
    Toure OA; Kouame MG; Didier YJ; Berenger AA; Djerea K; Genevieve GO; Penali LK
    Trop Med Int Health; 2011 Mar; 16(3):290-7. PubMed ID: 21214690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
    Hutagalung R; Paiphun L; Ashley EA; McGready R; Brockman A; Thwai KL; Singhasivanon P; Jelinek T; White NJ; Nosten FH
    Malar J; 2005 Sep; 4():46. PubMed ID: 16179089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coartem(®): a decade of patient-centric malaria management.
    Hamed K; Grueninger H
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):645-59. PubMed ID: 22554131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Ogutu B
    Expert Opin Pharmacother; 2013 Apr; 14(5):643-54. PubMed ID: 23419113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil.
    Alecrim MG; Lacerda MV; Mourão MP; Alecrim WD; Padilha A; Cardoso BS; Boulos M
    Am J Trop Med Hyg; 2006 Jan; 74(1):20-5. PubMed ID: 16407341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.
    Makanga M; Premji Z; Falade C; Karbwang J; Mueller EA; Andriano K; Hunt P; De Palacios PI
    Am J Trop Med Hyg; 2006 Jun; 74(6):991-8. PubMed ID: 16760509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
    Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
    Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].
    Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
    Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
    East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.
    Toure OA; Mwapasa V; Sagara I; Gaye O; Thompson R; Maheshwar AV; Mishra P; Behra N; Tshefu AK; Das RR; Anvikar AR; Sharma P; Roy A; Sharma SK; Nasa A; Jalali RK; Valecha N;
    Clin Infect Dis; 2017 Oct; 65(10):1711-1720. PubMed ID: 29020247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.